Related Experiment Video
Updated: Jul 14, 2026

08:06
The Use of a β-lactamase-based Conductimetric Biosensor Assay to Detect Biomolecular Interactions
Published on: February 1, 2018
A novel chemiluminescent substrate for detecting lactamase.
Tabassum Naqvi1, Rajendra Singh
1DiscoveRx Corporation, 42501 Albrae Street, Fremont, CA 94538, USA.
Molecular Biosystems
|May 30, 2007
Summary
This study introduces a novel chemiluminescent assay for beta-lactamase detection using enzyme fragment complementation. This sensitive reporter gene assay enables monitoring of cellular events, including G-protein coupled receptor activation.
Area of Science:
- Biochemistry
- Molecular Biology
- Assay Development
Background:
- Beta-lactamase is a key reporter enzyme for cellular events.
- Chemiluminescence is preferred for high-throughput screening.
- Enzyme fragment complementation offers sensitive detection.
Purpose of the Study:
- To develop the first chemiluminescent assay for beta-lactamase.
- To utilize beta-galactosidase based enzyme fragment complementation technology.
- To create a homogeneous cell-based reporter gene assay.
Main Methods:
- Employed enzyme fragment complementation with enzyme acceptor and donor fragments.
- Utilized a cyclic cephalosporin-based substrate for beta-lactamase.
- Developed a chemiluminescent read-out for beta-galactosidase activity.
- Applied the assay to monitor G-protein coupled receptor activation.
Main Results:
- Successfully developed a chemiluminescent beta-lactamase assay.
- Demonstrated the complementation of enzyme fragments upon substrate cleavage.
- Achieved sensitive detection in a homogeneous cell-based format.
- Validated the assay for monitoring GPCR activation.
Conclusions:
- The novel assay provides a sensitive, homogeneous, and chemiluminescent method for beta-lactamase detection.
- This technology is valuable for high-throughput screening and cellular event monitoring.
- The assay is effective for studying G-protein coupled receptor signaling pathways.
Related Concept Videos
Enzyme-Linked Immunosorbent Assay
In 1971, Peter Perlman and Eva Engvall developed an Enzyme-linked immunosorbent assay (ELISA or EIA). ELISA differs from western blot in that the assays are conducted in microtiter plates or in vivo rather than on an absorbent membrane.
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen. Enzyme-substrate reaction allows the antigen to be visualized or quantified.
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen. Enzyme-substrate reaction allows the antigen to be visualized or quantified.
Labeling DNA Probes
DNA probes are fragments of DNA labeled with a reporter tag to enable their detection or purification. The resulting labeled DNA probes can then hybridize to target nucleic acid sequences through complementary base-pairing, and may be used to recover or identify these regions.
Radioisotopes, fluorophores, or small molecule binding partners like biotin or digoxigenin, are the most widely used reporter tags for labeling DNA probes. These labels can be attached to the probe DNA molecule via...
Radioisotopes, fluorophores, or small molecule binding partners like biotin or digoxigenin, are the most widely used reporter tags for labeling DNA probes. These labels can be attached to the probe DNA molecule via...

